Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. [electronic resource]
Producer: 20030917Description: 2019-24 p. digitalISSN:- 1524-4628
- Adenosine Triphosphate -- metabolism
- Animals
- Blood-Brain Barrier -- drug effects
- Brain -- blood supply
- Cerebral Hemorrhage -- etiology
- Cerebrovascular Circulation -- drug effects
- Disease Models, Animal
- Disease Progression
- Elasticity
- Extravasation of Diagnostic and Therapeutic Materials
- Fibrin -- administration & dosage
- Gadolinium DTPA
- Infarction, Middle Cerebral Artery -- complications
- Intracranial Thrombosis -- complications
- Magnetic Resonance Angiography
- Male
- Rats
- Rats, Wistar
- Recombinant Proteins -- adverse effects
- Reperfusion -- methods
- Stroke -- complications
- Thrombin
- Thrombolytic Therapy -- methods
- Time Factors
- Tissue Plasminogen Activator -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.